Skip to content

Homeopathic medicines for high uric acid levels in blood

Treatment of hyperuricaemia with individualized homeopathic medicines: Double-blind, randomized, placebo-controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041991
Enrollment
60
Registered
2022-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
dosage and repeti

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 65 years 2. Patients of either sex 3. Suffering from hyperuricemia (ICD-10-CM code E79.0), i.e., SUA level above 7 mg/dl in men and above 6 mg/dl for women 4. Literate – ability to read Bengali and/or English 5. Willing to give written informed consent 6. If the patients are already undergoing treatment for hyperuricemia will be enrolled into the study after a wash-out period of one month subject to fulfilment of the eligibility criteria.

Exclusion criteria

Exclusion criteria: 1. Overt hyperuricemia (SUA levels more than 10 mg/dL) 2. Secondary gout, severe or advanced gout requiring surgical procedures or orthopedic corrections 3. Vulnerable population – unconscious, ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people 4. Unstable mental or psychiatric illness or other systemic diseases affecting quality of life or any vital organ failure 5. Currently receiving homoeopathic treatment for any chronic condition(s) 6. Self-reported immune-compromised state 7. Pregnant and puerperal women, lactating mothers 8. Patients with habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
Serum uric acid levelTimepoint: Baseline, and every month, up to 3 months

Secondary

MeasureTime frame
Hyperuricemia quality of life (HUQoL) total and subscale scoresTimepoint: Baseline, and every month, up to 3 months;EQ-5D-5L questionnaire scoreTimepoint: Baseline, and every month, up to 3 months;EQ-5D-5L visual analog scale (VAS) scoreTimepoint: Baseline, and every month, up to 3 months

Countries

India

Contacts

Public ContactRajat Chattopadhyay

The Calcutta Homoeopathic Medical College and Hospital

dr.rajatchatterjee@gmail.com9331041142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026